April, 2021 | Publication
Seraph 100 on 60 Minutes: Military Programs Aiming To End Pandemics Forever

Seraph 100 has been used to treat over 300 COVID-19 patients so far. 60 Minutes reports on its use in the military. Within days of being treated with the Seraph...

Read more
April, 2021 | Publication
Treating Covid-19 with the Blood Filter Seraph 100 – Klinikum Braunschweig

Klinikum Braunschweig; Seraph 100 binds SARS-CoV-2, the virus that causes COVID-19. Clinicians have anecdotally reported a reduction in inflammatory markers such as IL-6, d-dimers, and ferritin. Other anecdotal observations include...

Read more
March, 2021 | Press release
Lakhmir Chawla, MD, of Silver Creek Pharmaceuticals Joins ExThera Medical Board of Directors Outside of the Chair, ExThera Medical Board Composed Entirely of Outside Experts

MARTINEZ, Calif. – Professor Lakhmir Chawla, MD, has joined the board of directors of ExThera Medical Corporation, a privately held medical technology company whose Seraph 100 Microbind Affinity Blood Filter...

Read more
March, 2021 | Publication
First results of the COVID-19 patients treated with the Seraph® 100 Microbind® Affinity filter (COSA) registry

Background: The COVID-19 pandemic has serious impact on health and economics worldwide. Despite the recent advent of SARS-Cov-2 vaccines, treatment options are needed, yet pharmacologic interventions remain limited. Several extracorporeal...

Read more
January, 2021 | Publication
Treatment for Severe Coronavirus Disease 2019 with a biomimetic sorbent hemoperfusion device in patients on hemodialysis

Hemodialysis patients present more morbidity and mortality risk in coronavirus disease 2019. In patients who may develop severe symptoms the process called “viral sepsis” seems to be a crucial mechanism....

Read more
January, 2021 | Press release
Fresenius Medical Care expands critical care offering with ExThera Medical’s Seraph 100 adsorber

Fresenius Medical Care, the world’s leading provider of products and services for people with chronic kidney failure, will offer the Seraph 100 Microbind Affinity Blood Filter from ExThera Medical Corporation...

Read more
August, 2020 | Publication
Elimination of Staphylococcus aureus from the bloodstream using a novel biomimetic sorbent haemoperfusion device

Abstract Removal of bacteria from the blood by means of extracorporeal techniques has been attempted for decades. In late 2019, the European Union licensed the first ever haemoperfusion device for...

Read more
July, 2020 | Publication
Treatment for Severe Coronavirus Disease 2019 With the Seraph-100 Microbind Affinity Blood Filter

Objectives: To determine whether Seraph-100 (Exthera Medical Corporation, Martinez, CA) treatment provides clinical benefit for severe coronavirus disease 2019 cases that require mechanical ventilation and vasopressor support. Data Sources: The...

Read more
July, 2020 | Publication
Avoiding The Cytokine Storm

The cytokine storm, a severe, uncontrolled immune reaction characterized by an excessive release of cytokines into the bloodstream in a short period of time. This results in acute, pathological inflammation...

Read more
July, 2020 | Publication
Heparin 2.0: A New Approach to the Infection Crisis

In April 2020, the US Food and Drug Administration granted emergency use authorization for certain medical devices to be used in patients with coronavirus disease 2019 (COVID-19). This included extracorporeal...

Read more